FDA approves two sickle cell therapies, including first CRISPR medicine
The therapies offer hope for a long-overlooked genetic illness that can cause excruciating pain and cut decades off people’s lives.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news